STOCK TITAN

Afya Limited - AFYA STOCK NEWS

Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.

Afya Limited (Nasdaq: AFYA) is the leading medical education and digital health services provider in Brazil. Through its subsidiaries, Afya offers a comprehensive range of educational products and services, including medical schools, residency preparatory courses, and continuing education programs. Catering to lifelong medical learners, Afya operates across various disciplines such as medicine, dentistry, nursing, psychology, pharmacy, and more. The company also provides digital services like clinical decision software, practice management tools, and telemedicine solutions, supporting healthcare professionals at every stage of their careers. With substantial growth and significant market presence, Afya is committed to enhancing medical education and healthcare delivery throughout Brazil.

Rhea-AI Summary

Afya (Nasdaq: AFYA; B3: A2FY34) has announced that the Secretary of Regulation and Supervision of Higher Education of Brazil's Ministry of Education has approved an increase of 80 medical seats at Centro Universitário de Maceió (UNIMA Alagoas), totaling 220 seats at this institution.

This expansion will incur an additional payment of R$ 1.25 million per seat, adjusted by IPCA from January 2, 2023, until the payment date. This move contributes to Afya's total of 3,583 approved seats, reinforcing its position as a leading medical education provider in Brazil.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
none
-
Rhea-AI Summary

Afya has completed the acquisition of Unidompedro and Faculdade Dom Luiz, expanding its presence in Salvador, Brazil. The acquisition brings 300 operational medical school seats, with 125 fully authorized and 175 pending final judicial approval. Afya paid R$ 347.8 million upfront and will pay R$ 312.2 million over ten years, contingent on authorization maintenance. The purchase price could be adjusted based on legal outcomes. Projected Net Revenue for 2024 is R$ 110.5 million, growing to R$ 267 million by 2027. The estimated EV/EBITDA at maturity is 4.2x post synergies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
-
Rhea-AI Summary

Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education group in Brazil, announced the resignation of Mrs. Shobhna Mohn from its Board of Directors, effective June 30, 2024. Mohn's departure is unrelated to Afya’s operations or practices. During her tenure, she contributed significantly to Afya's growth, supporting its journey to becoming a top medical education and practice solutions provider in Brazil. Afya highlighted her strategic insights and leadership as pivotal to its success. The company has no immediate plans to fill her position. The board remains committed to strong governance with diverse skills and experience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.34%
Tags
management
Rhea-AI Summary

Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education and practice solutions provider in Brazil, announced the successful passage of a key resolution at its Annual General Meeting on June 5, 2024. Shareholders approved and ratified the company's financial statements and the auditor’s report for the fiscal year ending December 31, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
none
-
Rhea-AI Summary

Afya has announced its Annual General Meeting (AGM) scheduled for June 5, 2024, at 10:00 a.m. BRT. The meeting will take place at their Nova Lima office and virtually through a provided link. The main agenda item is the approval and ratification of the company's financial statements and the auditor's report for the fiscal year ending December 31, 2023. The record date for shareholders eligible to attend is May 10, 2024. The company encourages shareholders to participate and vote, either in person or via proxy. The company's financial statements are available on their investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.82%
Tags
none
-
Rhea-AI Summary

Afya reported solid financial results for the first quarter of 2024, with a 13.3% increase in net revenue to R$804.2 million and a 20.5% growth in adjusted EBITDA to R$397.9 million, leading to an adjusted EBITDA margin expansion of 300 bps. The company also saw significant increases in net income and adjusted net income. Afya's ecosystem reached 334,368 users, reflecting its strong presence in the medical education and practice solutions market in Brazil. The company reaffirmed its guidance for 2024, aiming for continued growth and acquisitions to enhance its offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
Rhea-AI Summary

Afya has announced the acquisition of Unidompedro and Faculdade Dom Luiz, adding 300 medical school seats in Brazil. The purchase price is R$660.0 million, with payment split between cash and installments. The transaction is subject to regulatory approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
-
Rhea-AI Summary
Afya reported strong financial and operating results for the fourth quarter and full-year period ended December 31, 2023. Highlights include a 22.6% increase in 4Q23 Adjusted Net Revenue to R$729.5 million, 19.3% growth in Adjusted EBITDA to R$288.9 million, and a 27.7% rise in Adjusted Net Income to R$164.4 million. For FY23, Adjusted Net Revenue increased by 23.9% to R$2,874.1 million, and Adjusted EBITDA grew by 21.2% to R$1,165.7 million. Cash conversion was at 97.1%, generating R$1,088.8 million in cash flow from operating activities. Afya's Digital Service saw an increase of 2.8% in monthly active physicians and medical students. The company also achieved its 2023 guidance and set new targets for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
-
Rhea-AI Summary
Afya Limited, a leading medical education group in Brazil, has received authorization to increase medical seats at FIP Guanambi, resulting in an additional payment of R$49.6 million. This brings Afya's total approved seats to 3,203.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
none
Rhea-AI Summary
Afya Limited (AFYA) Reports Strong Financial Results for Q3 2023, Showing 24.6% YoY Increase in Adjusted Net Revenue and 21.7% YoY Increase in Adjusted EBITDA. Cash Conversion of 109.3% Resulting in R$822.0 Million Solid Cash Position. Over 285 Thousand Monthly Active Physicians and Medical Students Using Afya’s Digital Service.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.39%
Tags

FAQ

What is the current stock price of Afya (AFYA)?

The current stock price of Afya (AFYA) is $15.5 as of December 20, 2024.

What is the market cap of Afya (AFYA)?

The market cap of Afya (AFYA) is approximately 1.4B.

What services does Afya Limited offer?

Afya Limited provides educational products and services such as medical schools, residency preparatory courses, continuing education programs, and digital health solutions like clinical decision software and telemedicine.

In which areas does Afya Limited operate?

Afya operates in various fields including medicine, dentistry, nursing, psychology, pharmacy, radiology, and more, offering both undergraduate and postgraduate programs.

How has Afya Limited performed financially?

Afya has shown substantial growth with increasing revenues and strong financial results, reflecting its successful business strategy and market presence.

What digital services does Afya Limited provide?

Afya offers a range of digital services including clinical decision software, practice management tools, electronic medical records, telemedicine, and digital prescriptions.

How does Afya support medical professionals?

Afya provides educational resources from undergraduate to continuing education, as well as digital tools to assist in clinical decision-making and practice management, empowering medical professionals throughout their careers.

Where is Afya Limited based?

Afya Limited is headquartered in Brazil and operates through its subsidiaries across the country, providing comprehensive educational and digital health services.

What are some recent achievements of Afya Limited?

Afya has recently expanded its medical seats, integrated new acquisitions, and achieved significant financial growth, reaffirming its strong market position.

What is Afya's approach to sustainability and ESG?

Afya is committed to sustainability and ESG principles, advancing core pillars such as gender equality, renewable energy use, and social responsibility in healthcare education.

How extensive is Afya’s digital health services footprint?

Afya’s digital health services include tools and platforms used by nearly 334,000 monthly active physicians and medical students, enhancing healthcare delivery and education.

What is Afya's mission?

Afya's mission is to provide an ecosystem that integrates education and digital solutions for the entire medical journey, supporting the development and efficiency of healthcare professionals.

Afya Limited

Nasdaq:AFYA

AFYA Rankings

AFYA Stock Data

1.38B
13.68M
84.14%
23.06%
1.09%
Education & Training Services
Consumer Defensive
Link
United States of America
Nova Lima